nodes	percent_of_prediction	percent_of_DWPC	metapath
Melatonin—CYP1B1—Mitoxantrone—multiple sclerosis	0.134	0.286	CbGbCtD
Melatonin—CYP19A1—Betamethasone—multiple sclerosis	0.0968	0.207	CbGbCtD
Melatonin—CYP1B1—Dexamethasone—multiple sclerosis	0.0695	0.148	CbGbCtD
Melatonin—CYP19A1—Dexamethasone—multiple sclerosis	0.0563	0.12	CbGbCtD
Melatonin—SLC22A8—Methotrexate—multiple sclerosis	0.0308	0.0658	CbGbCtD
Melatonin—CYP1A1—Dexamethasone—multiple sclerosis	0.0305	0.0651	CbGbCtD
Melatonin—CYP2C19—Prednisone—multiple sclerosis	0.0236	0.0505	CbGbCtD
Melatonin—ASMT—pineal body—multiple sclerosis	0.0174	0.119	CbGeAlD
Melatonin—CYP2C19—Dexamethasone—multiple sclerosis	0.0148	0.0315	CbGbCtD
Melatonin—CYP2C9—Dexamethasone—multiple sclerosis	0.0123	0.0262	CbGbCtD
Melatonin—MT3—nerve—multiple sclerosis	0.0086	0.0589	CbGeAlD
Melatonin—CALM1—trigeminal nerve—multiple sclerosis	0.00567	0.0388	CbGeAlD
Melatonin—MTNR1B—retina—multiple sclerosis	0.00538	0.0368	CbGeAlD
Melatonin—ASMT—retina—multiple sclerosis	0.00524	0.0359	CbGeAlD
Melatonin—CALM2—pons—multiple sclerosis	0.00401	0.0275	CbGeAlD
Melatonin—CALM1—pons—multiple sclerosis	0.00399	0.0273	CbGeAlD
Melatonin—MT3—brainstem—multiple sclerosis	0.00369	0.0253	CbGeAlD
Melatonin—CALR—brainstem—multiple sclerosis	0.00291	0.02	CbGeAlD
Melatonin—CALM2—pineal body—multiple sclerosis	0.00286	0.0196	CbGeAlD
Melatonin—CALM1—pineal body—multiple sclerosis	0.00285	0.0195	CbGeAlD
Melatonin—ASMT—nervous system—multiple sclerosis	0.00285	0.0195	CbGeAlD
Melatonin—CALR—retina—multiple sclerosis	0.00281	0.0193	CbGeAlD
Melatonin—ASMT—central nervous system—multiple sclerosis	0.00274	0.0188	CbGeAlD
Melatonin—CALM2—peripheral nervous system—multiple sclerosis	0.00267	0.0183	CbGeAlD
Melatonin—CALM1—peripheral nervous system—multiple sclerosis	0.00265	0.0182	CbGeAlD
Melatonin—MT3—medulla oblongata—multiple sclerosis	0.00257	0.0176	CbGeAlD
Melatonin—MTNR1A—nervous system—multiple sclerosis	0.00231	0.0158	CbGeAlD
Melatonin—MT3—spinal cord—multiple sclerosis	0.0023	0.0157	CbGeAlD
Melatonin—MTNR1A—central nervous system—multiple sclerosis	0.00222	0.0152	CbGeAlD
Melatonin—ASMT—brain—multiple sclerosis	0.00218	0.0149	CbGeAlD
Melatonin—CALM2—nerve—multiple sclerosis	0.00208	0.0142	CbGeAlD
Melatonin—CALM1—nerve—multiple sclerosis	0.00207	0.0142	CbGeAlD
Melatonin—CALR—medulla oblongata—multiple sclerosis	0.00203	0.0139	CbGeAlD
Melatonin—MT3—nervous system—multiple sclerosis	0.00193	0.0133	CbGeAlD
Melatonin—MT3—central nervous system—multiple sclerosis	0.00186	0.0128	CbGeAlD
Melatonin—CALR—midbrain—multiple sclerosis	0.00186	0.0127	CbGeAlD
Melatonin—MT3—cerebellum—multiple sclerosis	0.00182	0.0125	CbGeAlD
Melatonin—CALR—spinal cord—multiple sclerosis	0.00181	0.0124	CbGeAlD
Melatonin—MTNR1A—brain—multiple sclerosis	0.00176	0.0121	CbGeAlD
Melatonin—NQO2—brainstem—multiple sclerosis	0.00164	0.0113	CbGeAlD
Melatonin—CALR—nervous system—multiple sclerosis	0.00153	0.0105	CbGeAlD
Melatonin—MT3—brain—multiple sclerosis	0.00148	0.0101	CbGeAlD
Melatonin—CALR—central nervous system—multiple sclerosis	0.00147	0.0101	CbGeAlD
Melatonin—CALR—cerebellum—multiple sclerosis	0.00144	0.00984	CbGeAlD
Melatonin—CALR—brain—multiple sclerosis	0.00117	0.00799	CbGeAlD
Melatonin—NQO2—medulla oblongata—multiple sclerosis	0.00115	0.00785	CbGeAlD
Melatonin—CALM3—retina—multiple sclerosis	0.0011	0.00751	CbGeAlD
Melatonin—NQO2—midbrain—multiple sclerosis	0.00105	0.00717	CbGeAlD
Melatonin—NQO2—spinal cord—multiple sclerosis	0.00102	0.007	CbGeAlD
Melatonin—ESR1—brainstem—multiple sclerosis	0.000898	0.00615	CbGeAlD
Melatonin—CALM2—brainstem—multiple sclerosis	0.000893	0.00612	CbGeAlD
Melatonin—CALM1—brainstem—multiple sclerosis	0.000889	0.00609	CbGeAlD
Melatonin—CALM2—retina—multiple sclerosis	0.000861	0.0059	CbGeAlD
Melatonin—NQO2—nervous system—multiple sclerosis	0.000861	0.0059	CbGeAlD
Melatonin—CALM1—retina—multiple sclerosis	0.000857	0.00587	CbGeAlD
Melatonin—NQO2—central nervous system—multiple sclerosis	0.000829	0.00568	CbGeAlD
Melatonin—NQO2—cerebellum—multiple sclerosis	0.00081	0.00555	CbGeAlD
Melatonin—CALM3—medulla oblongata—multiple sclerosis	0.000793	0.00543	CbGeAlD
Melatonin—MPO—spinal cord—multiple sclerosis	0.000786	0.00539	CbGeAlD
Melatonin—CALM3—midbrain—multiple sclerosis	0.000724	0.00496	CbGeAlD
Melatonin—CALM3—spinal cord—multiple sclerosis	0.000707	0.00484	CbGeAlD
Melatonin—MPO—nervous system—multiple sclerosis	0.000663	0.00454	CbGeAlD
Melatonin—NQO2—brain—multiple sclerosis	0.000658	0.00451	CbGeAlD
Melatonin—MPO—central nervous system—multiple sclerosis	0.000638	0.00437	CbGeAlD
Melatonin—CALM2—medulla oblongata—multiple sclerosis	0.000622	0.00426	CbGeAlD
Melatonin—CALM1—medulla oblongata—multiple sclerosis	0.00062	0.00424	CbGeAlD
Melatonin—CALM2—midbrain—multiple sclerosis	0.000569	0.0039	CbGeAlD
Melatonin—CALM1—midbrain—multiple sclerosis	0.000566	0.00388	CbGeAlD
Melatonin—CALM3—cerebellum—multiple sclerosis	0.00056	0.00384	CbGeAlD
Melatonin—CALM2—spinal cord—multiple sclerosis	0.000555	0.0038	CbGeAlD
Melatonin—CALM1—spinal cord—multiple sclerosis	0.000552	0.00379	CbGeAlD
Melatonin—CYP19A1—nervous system—multiple sclerosis	0.000541	0.00371	CbGeAlD
Melatonin—SLC22A8—nervous system—multiple sclerosis	0.00053	0.00363	CbGeAlD
Melatonin—CYP19A1—central nervous system—multiple sclerosis	0.000521	0.00357	CbGeAlD
Melatonin—SLC22A8—central nervous system—multiple sclerosis	0.00051	0.00349	CbGeAlD
Melatonin—MPO—brain—multiple sclerosis	0.000506	0.00347	CbGeAlD
Melatonin—CYP1B1—nervous system—multiple sclerosis	0.000506	0.00347	CbGeAlD
Melatonin—CYP1B1—central nervous system—multiple sclerosis	0.000487	0.00334	CbGeAlD
Melatonin—CYP1B1—cerebellum—multiple sclerosis	0.000476	0.00326	CbGeAlD
Melatonin—ESR1—nervous system—multiple sclerosis	0.000471	0.00322	CbGeAlD
Melatonin—CALM2—nervous system—multiple sclerosis	0.000468	0.0032	CbGeAlD
Melatonin—CALM1—nervous system—multiple sclerosis	0.000466	0.00319	CbGeAlD
Melatonin—CALM3—brain—multiple sclerosis	0.000455	0.00312	CbGeAlD
Melatonin—ESR1—central nervous system—multiple sclerosis	0.000453	0.0031	CbGeAlD
Melatonin—CALM2—central nervous system—multiple sclerosis	0.00045	0.00308	CbGeAlD
Melatonin—CALM1—central nervous system—multiple sclerosis	0.000448	0.00307	CbGeAlD
Melatonin—ESR1—cerebellum—multiple sclerosis	0.000443	0.00303	CbGeAlD
Melatonin—CALM2—cerebellum—multiple sclerosis	0.00044	0.00302	CbGeAlD
Melatonin—CALM1—cerebellum—multiple sclerosis	0.000438	0.003	CbGeAlD
Melatonin—CYP19A1—brain—multiple sclerosis	0.000414	0.00284	CbGeAlD
Melatonin—SLC22A8—brain—multiple sclerosis	0.000405	0.00277	CbGeAlD
Melatonin—CYP1B1—brain—multiple sclerosis	0.000387	0.00265	CbGeAlD
Melatonin—ESR1—brain—multiple sclerosis	0.00036	0.00246	CbGeAlD
Melatonin—CYP1A1—nervous system—multiple sclerosis	0.000358	0.00245	CbGeAlD
Melatonin—CALM2—brain—multiple sclerosis	0.000357	0.00245	CbGeAlD
Melatonin—CALM1—brain—multiple sclerosis	0.000356	0.00244	CbGeAlD
Melatonin—CYP1A1—central nervous system—multiple sclerosis	0.000344	0.00236	CbGeAlD
Melatonin—Abdominal pain—Azathioprine—multiple sclerosis	0.000296	0.00176	CcSEcCtD
Melatonin—Skin disorder—Mitoxantrone—multiple sclerosis	0.000294	0.00175	CcSEcCtD
Melatonin—Irritability—Methotrexate—multiple sclerosis	0.000293	0.00174	CcSEcCtD
Melatonin—Vomiting—Cladribine—multiple sclerosis	0.000293	0.00174	CcSEcCtD
Melatonin—Angiopathy—Methylprednisolone—multiple sclerosis	0.000291	0.00173	CcSEcCtD
Melatonin—Mood swings—Methotrexate—multiple sclerosis	0.000291	0.00173	CcSEcCtD
Melatonin—Rash—Cladribine—multiple sclerosis	0.000291	0.00173	CcSEcCtD
Melatonin—Dermatitis—Cladribine—multiple sclerosis	0.00029	0.00173	CcSEcCtD
Melatonin—Immune system disorder—Methylprednisolone—multiple sclerosis	0.00029	0.00173	CcSEcCtD
Melatonin—Weight increased—Prednisone—multiple sclerosis	0.000289	0.00172	CcSEcCtD
Melatonin—Headache—Cladribine—multiple sclerosis	0.000289	0.00172	CcSEcCtD
Melatonin—Vision blurred—Prednisolone—multiple sclerosis	0.000287	0.00171	CcSEcCtD
Melatonin—Liver function test abnormal—Methotrexate—multiple sclerosis	0.000284	0.00169	CcSEcCtD
Melatonin—Mental disorder—Methylprednisolone—multiple sclerosis	0.000281	0.00167	CcSEcCtD
Melatonin—Erythema—Triamcinolone—multiple sclerosis	0.00028	0.00167	CcSEcCtD
Melatonin—Erythema—Methylprednisolone—multiple sclerosis	0.00028	0.00166	CcSEcCtD
Melatonin—Malnutrition—Methylprednisolone—multiple sclerosis	0.00028	0.00166	CcSEcCtD
Melatonin—Angioedema—Prednisolone—multiple sclerosis	0.000278	0.00166	CcSEcCtD
Melatonin—Breast disorder—Methotrexate—multiple sclerosis	0.000278	0.00165	CcSEcCtD
Melatonin—Hypersensitivity—Azathioprine—multiple sclerosis	0.000276	0.00164	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000276	0.00164	CcSEcCtD
Melatonin—Nausea—Cladribine—multiple sclerosis	0.000274	0.00163	CcSEcCtD
Melatonin—Vertigo—Prednisolone—multiple sclerosis	0.000274	0.00163	CcSEcCtD
Melatonin—CYP1A1—brain—multiple sclerosis	0.000273	0.00187	CbGeAlD
Melatonin—Syncope—Prednisolone—multiple sclerosis	0.000273	0.00163	CcSEcCtD
Melatonin—Eye disorder—Dexamethasone—multiple sclerosis	0.000273	0.00162	CcSEcCtD
Melatonin—Eye disorder—Betamethasone—multiple sclerosis	0.000273	0.00162	CcSEcCtD
Melatonin—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000272	0.00162	CcSEcCtD
Melatonin—Back pain—Triamcinolone—multiple sclerosis	0.000271	0.00161	CcSEcCtD
Melatonin—Somnolence—Mitoxantrone—multiple sclerosis	0.000269	0.0016	CcSEcCtD
Melatonin—Loss of consciousness—Prednisolone—multiple sclerosis	0.000268	0.00159	CcSEcCtD
Melatonin—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000267	0.00159	CcSEcCtD
Melatonin—Angiopathy—Dexamethasone—multiple sclerosis	0.000265	0.00158	CcSEcCtD
Melatonin—Angiopathy—Betamethasone—multiple sclerosis	0.000265	0.00158	CcSEcCtD
Melatonin—Hypertension—Prednisolone—multiple sclerosis	0.000263	0.00156	CcSEcCtD
Melatonin—Fatigue—Mitoxantrone—multiple sclerosis	0.000261	0.00155	CcSEcCtD
Melatonin—Pain—Mitoxantrone—multiple sclerosis	0.000259	0.00154	CcSEcCtD
Melatonin—Angioedema—Triamcinolone—multiple sclerosis	0.000256	0.00152	CcSEcCtD
Melatonin—Angioedema—Methylprednisolone—multiple sclerosis	0.000255	0.00152	CcSEcCtD
Melatonin—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000255	0.00151	CcSEcCtD
Melatonin—Erythema—Betamethasone—multiple sclerosis	0.000254	0.00151	CcSEcCtD
Melatonin—Erythema—Dexamethasone—multiple sclerosis	0.000254	0.00151	CcSEcCtD
Melatonin—Vertigo—Triamcinolone—multiple sclerosis	0.000252	0.0015	CcSEcCtD
Melatonin—Syncope—Triamcinolone—multiple sclerosis	0.000251	0.00149	CcSEcCtD
Melatonin—Vertigo—Methylprednisolone—multiple sclerosis	0.000251	0.00149	CcSEcCtD
Melatonin—Syncope—Methylprednisolone—multiple sclerosis	0.000251	0.00149	CcSEcCtD
Melatonin—Connective tissue disorder—Prednisone—multiple sclerosis	0.00025	0.00149	CcSEcCtD
Melatonin—Dizziness—Azathioprine—multiple sclerosis	0.000248	0.00147	CcSEcCtD
Melatonin—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000248	0.00147	CcSEcCtD
Melatonin—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000246	0.00146	CcSEcCtD
Melatonin—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000246	0.00146	CcSEcCtD
Melatonin—Shock—Prednisolone—multiple sclerosis	0.000245	0.00145	CcSEcCtD
Melatonin—Hypertension—Triamcinolone—multiple sclerosis	0.000242	0.00144	CcSEcCtD
Melatonin—Hypertension—Methylprednisolone—multiple sclerosis	0.000241	0.00144	CcSEcCtD
Melatonin—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00024	0.00142	CcSEcCtD
Melatonin—Vomiting—Azathioprine—multiple sclerosis	0.000238	0.00142	CcSEcCtD
Melatonin—Arthralgia—Methylprednisolone—multiple sclerosis	0.000238	0.00142	CcSEcCtD
Melatonin—Eye disorder—Prednisone—multiple sclerosis	0.000238	0.00141	CcSEcCtD
Melatonin—Anxiety—Methylprednisolone—multiple sclerosis	0.000237	0.00141	CcSEcCtD
Melatonin—Infestation NOS—Methotrexate—multiple sclerosis	0.000237	0.00141	CcSEcCtD
Melatonin—Infestation—Methotrexate—multiple sclerosis	0.000237	0.00141	CcSEcCtD
Melatonin—Rash—Azathioprine—multiple sclerosis	0.000236	0.00141	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000236	0.00141	CcSEcCtD
Melatonin—Dermatitis—Azathioprine—multiple sclerosis	0.000236	0.0014	CcSEcCtD
Melatonin—Headache—Azathioprine—multiple sclerosis	0.000235	0.0014	CcSEcCtD
Melatonin—Dry mouth—Triamcinolone—multiple sclerosis	0.000233	0.00139	CcSEcCtD
Melatonin—Angioedema—Dexamethasone—multiple sclerosis	0.000232	0.00138	CcSEcCtD
Melatonin—Angioedema—Betamethasone—multiple sclerosis	0.000232	0.00138	CcSEcCtD
Melatonin—Stomatitis—Methotrexate—multiple sclerosis	0.000231	0.00137	CcSEcCtD
Melatonin—Angiopathy—Prednisone—multiple sclerosis	0.000231	0.00137	CcSEcCtD
Melatonin—Immune system disorder—Prednisone—multiple sclerosis	0.00023	0.00137	CcSEcCtD
Melatonin—Vertigo—Dexamethasone—multiple sclerosis	0.000228	0.00136	CcSEcCtD
Melatonin—Vertigo—Betamethasone—multiple sclerosis	0.000228	0.00136	CcSEcCtD
Melatonin—Syncope—Betamethasone—multiple sclerosis	0.000228	0.00136	CcSEcCtD
Melatonin—Syncope—Dexamethasone—multiple sclerosis	0.000228	0.00136	CcSEcCtD
Melatonin—Infection—Triamcinolone—multiple sclerosis	0.000227	0.00135	CcSEcCtD
Melatonin—Infection—Methylprednisolone—multiple sclerosis	0.000227	0.00135	CcSEcCtD
Melatonin—Haematuria—Methotrexate—multiple sclerosis	0.000226	0.00134	CcSEcCtD
Melatonin—Shock—Triamcinolone—multiple sclerosis	0.000225	0.00134	CcSEcCtD
Melatonin—Insomnia—Prednisolone—multiple sclerosis	0.000225	0.00134	CcSEcCtD
Melatonin—Shock—Methylprednisolone—multiple sclerosis	0.000224	0.00134	CcSEcCtD
Melatonin—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000224	0.00133	CcSEcCtD
Melatonin—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000224	0.00133	CcSEcCtD
Melatonin—Loss of consciousness—Betamethasone—multiple sclerosis	0.000223	0.00133	CcSEcCtD
Melatonin—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000223	0.00133	CcSEcCtD
Melatonin—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000223	0.00133	CcSEcCtD
Melatonin—Paraesthesia—Prednisolone—multiple sclerosis	0.000223	0.00133	CcSEcCtD
Melatonin—Mental disorder—Prednisone—multiple sclerosis	0.000223	0.00133	CcSEcCtD
Melatonin—Nausea—Azathioprine—multiple sclerosis	0.000223	0.00132	CcSEcCtD
Melatonin—Skin disorder—Methylprednisolone—multiple sclerosis	0.000222	0.00132	CcSEcCtD
Melatonin—Erythema—Prednisone—multiple sclerosis	0.000221	0.00132	CcSEcCtD
Melatonin—Malnutrition—Prednisone—multiple sclerosis	0.000221	0.00132	CcSEcCtD
Melatonin—Hypertension—Betamethasone—multiple sclerosis	0.000219	0.00131	CcSEcCtD
Melatonin—Hypertension—Dexamethasone—multiple sclerosis	0.000219	0.00131	CcSEcCtD
Melatonin—Asthenia—Mitoxantrone—multiple sclerosis	0.000217	0.00129	CcSEcCtD
Melatonin—Anxiety—Betamethasone—multiple sclerosis	0.000216	0.00128	CcSEcCtD
Melatonin—Anxiety—Dexamethasone—multiple sclerosis	0.000216	0.00128	CcSEcCtD
Melatonin—Pain—Prednisolone—multiple sclerosis	0.000213	0.00126	CcSEcCtD
Melatonin—Urinary tract disorder—Methotrexate—multiple sclerosis	0.00021	0.00125	CcSEcCtD
Melatonin—Vision blurred—Prednisone—multiple sclerosis	0.000209	0.00124	CcSEcCtD
Melatonin—Urethral disorder—Methotrexate—multiple sclerosis	0.000208	0.00124	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000208	0.00124	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000208	0.00124	CcSEcCtD
Melatonin—Insomnia—Triamcinolone—multiple sclerosis	0.000207	0.00123	CcSEcCtD
Melatonin—Insomnia—Methylprednisolone—multiple sclerosis	0.000206	0.00123	CcSEcCtD
Melatonin—Infection—Betamethasone—multiple sclerosis	0.000206	0.00123	CcSEcCtD
Melatonin—Infection—Dexamethasone—multiple sclerosis	0.000206	0.00123	CcSEcCtD
Melatonin—Paraesthesia—Triamcinolone—multiple sclerosis	0.000205	0.00122	CcSEcCtD
Melatonin—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000205	0.00122	CcSEcCtD
Melatonin—Shock—Betamethasone—multiple sclerosis	0.000204	0.00121	CcSEcCtD
Melatonin—Shock—Dexamethasone—multiple sclerosis	0.000204	0.00121	CcSEcCtD
Melatonin—Nervous system disorder—Betamethasone—multiple sclerosis	0.000203	0.00121	CcSEcCtD
Melatonin—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000203	0.00121	CcSEcCtD
Melatonin—Agitation—Prednisone—multiple sclerosis	0.000203	0.00121	CcSEcCtD
Melatonin—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000203	0.00121	CcSEcCtD
Melatonin—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000203	0.00121	CcSEcCtD
Melatonin—Angioedema—Prednisone—multiple sclerosis	0.000202	0.0012	CcSEcCtD
Melatonin—Dyspepsia—Triamcinolone—multiple sclerosis	0.000201	0.0012	CcSEcCtD
Melatonin—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000201	0.00119	CcSEcCtD
Melatonin—Vertigo—Prednisone—multiple sclerosis	0.000199	0.00118	CcSEcCtD
Melatonin—Eye disorder—Methotrexate—multiple sclerosis	0.000199	0.00118	CcSEcCtD
Melatonin—Syncope—Prednisone—multiple sclerosis	0.000199	0.00118	CcSEcCtD
Melatonin—Cardiac disorder—Methotrexate—multiple sclerosis	0.000197	0.00117	CcSEcCtD
Melatonin—Fatigue—Triamcinolone—multiple sclerosis	0.000197	0.00117	CcSEcCtD
Melatonin—Fatigue—Methylprednisolone—multiple sclerosis	0.000197	0.00117	CcSEcCtD
Melatonin—Pain—Triamcinolone—multiple sclerosis	0.000196	0.00116	CcSEcCtD
Melatonin—Loss of consciousness—Prednisone—multiple sclerosis	0.000195	0.00116	CcSEcCtD
Melatonin—Angiopathy—Methotrexate—multiple sclerosis	0.000193	0.00115	CcSEcCtD
Melatonin—Vomiting—Mitoxantrone—multiple sclerosis	0.000193	0.00115	CcSEcCtD
Melatonin—Immune system disorder—Methotrexate—multiple sclerosis	0.000192	0.00114	CcSEcCtD
Melatonin—Hypertension—Prednisone—multiple sclerosis	0.000191	0.00114	CcSEcCtD
Melatonin—Rash—Mitoxantrone—multiple sclerosis	0.000191	0.00114	CcSEcCtD
Melatonin—Dermatitis—Mitoxantrone—multiple sclerosis	0.000191	0.00114	CcSEcCtD
Melatonin—Headache—Mitoxantrone—multiple sclerosis	0.00019	0.00113	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000189	0.00112	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000189	0.00112	CcSEcCtD
Melatonin—Arthralgia—Prednisone—multiple sclerosis	0.000188	0.00112	CcSEcCtD
Melatonin—Anxiety—Prednisone—multiple sclerosis	0.000188	0.00112	CcSEcCtD
Melatonin—Insomnia—Betamethasone—multiple sclerosis	0.000188	0.00112	CcSEcCtD
Melatonin—Insomnia—Dexamethasone—multiple sclerosis	0.000188	0.00112	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000187	0.00111	CcSEcCtD
Melatonin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000187	0.00111	CcSEcCtD
Melatonin—Paraesthesia—Dexamethasone—multiple sclerosis	0.000186	0.00111	CcSEcCtD
Melatonin—Paraesthesia—Betamethasone—multiple sclerosis	0.000186	0.00111	CcSEcCtD
Melatonin—Mental disorder—Methotrexate—multiple sclerosis	0.000186	0.00111	CcSEcCtD
Melatonin—Malnutrition—Methotrexate—multiple sclerosis	0.000185	0.0011	CcSEcCtD
Melatonin—Erythema—Methotrexate—multiple sclerosis	0.000185	0.0011	CcSEcCtD
Melatonin—Hypersensitivity—Prednisolone—multiple sclerosis	0.000183	0.00109	CcSEcCtD
Melatonin—Dyspepsia—Betamethasone—multiple sclerosis	0.000183	0.00109	CcSEcCtD
Melatonin—Dyspepsia—Dexamethasone—multiple sclerosis	0.000183	0.00109	CcSEcCtD
Melatonin—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00018	0.00107	CcSEcCtD
Melatonin—Nausea—Mitoxantrone—multiple sclerosis	0.00018	0.00107	CcSEcCtD
Melatonin—Infection—Prednisone—multiple sclerosis	0.000179	0.00107	CcSEcCtD
Melatonin—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000179	0.00107	CcSEcCtD
Melatonin—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000179	0.00107	CcSEcCtD
Melatonin—Back pain—Methotrexate—multiple sclerosis	0.000179	0.00106	CcSEcCtD
Melatonin—Fatigue—Betamethasone—multiple sclerosis	0.000179	0.00106	CcSEcCtD
Melatonin—Fatigue—Dexamethasone—multiple sclerosis	0.000179	0.00106	CcSEcCtD
Melatonin—Shock—Prednisone—multiple sclerosis	0.000178	0.00106	CcSEcCtD
Melatonin—Pain—Dexamethasone—multiple sclerosis	0.000177	0.00106	CcSEcCtD
Melatonin—Pain—Betamethasone—multiple sclerosis	0.000177	0.00106	CcSEcCtD
Melatonin—Nervous system disorder—Prednisone—multiple sclerosis	0.000177	0.00105	CcSEcCtD
Melatonin—Skin disorder—Prednisone—multiple sclerosis	0.000175	0.00104	CcSEcCtD
Melatonin—Vision blurred—Methotrexate—multiple sclerosis	0.000174	0.00104	CcSEcCtD
Melatonin—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00017	0.00101	CcSEcCtD
Melatonin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00017	0.00101	CcSEcCtD
Melatonin—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000168	0.001	CcSEcCtD
Melatonin—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000168	0.001	CcSEcCtD
Melatonin—Vertigo—Methotrexate—multiple sclerosis	0.000166	0.000989	CcSEcCtD
Melatonin—Leukopenia—Methotrexate—multiple sclerosis	0.000166	0.000985	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000165	0.000979	CcSEcCtD
Melatonin—Dizziness—Prednisolone—multiple sclerosis	0.000164	0.000978	CcSEcCtD
Melatonin—Asthenia—Triamcinolone—multiple sclerosis	0.000164	0.000976	CcSEcCtD
Melatonin—Abdominal pain—Betamethasone—multiple sclerosis	0.000164	0.000975	CcSEcCtD
Melatonin—Abdominal pain—Dexamethasone—multiple sclerosis	0.000164	0.000975	CcSEcCtD
Melatonin—Asthenia—Methylprednisolone—multiple sclerosis	0.000164	0.000974	CcSEcCtD
Melatonin—Insomnia—Prednisone—multiple sclerosis	0.000163	0.000972	CcSEcCtD
Melatonin—Paraesthesia—Prednisone—multiple sclerosis	0.000162	0.000965	CcSEcCtD
Melatonin—Pruritus—Triamcinolone—multiple sclerosis	0.000162	0.000962	CcSEcCtD
Melatonin—Pruritus—Methylprednisolone—multiple sclerosis	0.000161	0.00096	CcSEcCtD
Melatonin—Dyspepsia—Prednisone—multiple sclerosis	0.000159	0.000946	CcSEcCtD
Melatonin—Arthralgia—Methotrexate—multiple sclerosis	0.000158	0.000937	CcSEcCtD
Melatonin—Chest pain—Methotrexate—multiple sclerosis	0.000158	0.000937	CcSEcCtD
Melatonin—Rash—Prednisolone—multiple sclerosis	0.000157	0.000932	CcSEcCtD
Melatonin—Dermatitis—Prednisolone—multiple sclerosis	0.000157	0.000932	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000156	0.00093	CcSEcCtD
Melatonin—Fatigue—Prednisone—multiple sclerosis	0.000156	0.000927	CcSEcCtD
Melatonin—Headache—Prednisolone—multiple sclerosis	0.000156	0.000926	CcSEcCtD
Melatonin—Dizziness—Triamcinolone—multiple sclerosis	0.000151	0.000899	CcSEcCtD
Melatonin—Dizziness—Methylprednisolone—multiple sclerosis	0.000151	0.000897	CcSEcCtD
Melatonin—Infection—Methotrexate—multiple sclerosis	0.00015	0.000892	CcSEcCtD
Melatonin—Asthenia—Dexamethasone—multiple sclerosis	0.000149	0.000885	CcSEcCtD
Melatonin—Asthenia—Betamethasone—multiple sclerosis	0.000149	0.000885	CcSEcCtD
Melatonin—Nervous system disorder—Methotrexate—multiple sclerosis	0.000148	0.000881	CcSEcCtD
Melatonin—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000148	0.000879	CcSEcCtD
Melatonin—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000148	0.000879	CcSEcCtD
Melatonin—Nausea—Prednisolone—multiple sclerosis	0.000148	0.000878	CcSEcCtD
Melatonin—Pruritus—Dexamethasone—multiple sclerosis	0.000147	0.000873	CcSEcCtD
Melatonin—Pruritus—Betamethasone—multiple sclerosis	0.000147	0.000873	CcSEcCtD
Melatonin—Skin disorder—Methotrexate—multiple sclerosis	0.000147	0.000872	CcSEcCtD
Melatonin—Vomiting—Triamcinolone—multiple sclerosis	0.000145	0.000865	CcSEcCtD
Melatonin—Vomiting—Methylprednisolone—multiple sclerosis	0.000145	0.000863	CcSEcCtD
Melatonin—Rash—Triamcinolone—multiple sclerosis	0.000144	0.000858	CcSEcCtD
Melatonin—Dermatitis—Triamcinolone—multiple sclerosis	0.000144	0.000857	CcSEcCtD
Melatonin—Rash—Methylprednisolone—multiple sclerosis	0.000144	0.000856	CcSEcCtD
Melatonin—Dermatitis—Methylprednisolone—multiple sclerosis	0.000144	0.000855	CcSEcCtD
Melatonin—Headache—Triamcinolone—multiple sclerosis	0.000143	0.000852	CcSEcCtD
Melatonin—Headache—Methylprednisolone—multiple sclerosis	0.000143	0.00085	CcSEcCtD
Melatonin—Abdominal pain—Prednisone—multiple sclerosis	0.000143	0.00085	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000138	0.000818	CcSEcCtD
Melatonin—Dizziness—Betamethasone—multiple sclerosis	0.000137	0.000816	CcSEcCtD
Melatonin—Dizziness—Dexamethasone—multiple sclerosis	0.000137	0.000816	CcSEcCtD
Melatonin—Insomnia—Methotrexate—multiple sclerosis	0.000137	0.000812	CcSEcCtD
Melatonin—Nausea—Triamcinolone—multiple sclerosis	0.000136	0.000808	CcSEcCtD
Melatonin—Paraesthesia—Methotrexate—multiple sclerosis	0.000136	0.000806	CcSEcCtD
Melatonin—Nausea—Methylprednisolone—multiple sclerosis	0.000136	0.000806	CcSEcCtD
Melatonin—Somnolence—Methotrexate—multiple sclerosis	0.000134	0.000798	CcSEcCtD
Melatonin—Hypersensitivity—Prednisone—multiple sclerosis	0.000133	0.000792	CcSEcCtD
Melatonin—Dyspepsia—Methotrexate—multiple sclerosis	0.000133	0.000791	CcSEcCtD
Melatonin—Vomiting—Betamethasone—multiple sclerosis	0.000132	0.000785	CcSEcCtD
Melatonin—Vomiting—Dexamethasone—multiple sclerosis	0.000132	0.000785	CcSEcCtD
Melatonin—Rash—Betamethasone—multiple sclerosis	0.000131	0.000778	CcSEcCtD
Melatonin—Rash—Dexamethasone—multiple sclerosis	0.000131	0.000778	CcSEcCtD
Melatonin—Dermatitis—Betamethasone—multiple sclerosis	0.000131	0.000777	CcSEcCtD
Melatonin—Dermatitis—Dexamethasone—multiple sclerosis	0.000131	0.000777	CcSEcCtD
Melatonin—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.00013	0.000775	CcSEcCtD
Melatonin—Fatigue—Methotrexate—multiple sclerosis	0.00013	0.000774	CcSEcCtD
Melatonin—Headache—Dexamethasone—multiple sclerosis	0.00013	0.000773	CcSEcCtD
Melatonin—Headache—Betamethasone—multiple sclerosis	0.00013	0.000773	CcSEcCtD
Melatonin—Asthenia—Prednisone—multiple sclerosis	0.00013	0.000771	CcSEcCtD
Melatonin—Pain—Methotrexate—multiple sclerosis	0.000129	0.000768	CcSEcCtD
Melatonin—Pruritus—Prednisone—multiple sclerosis	0.000128	0.00076	CcSEcCtD
Melatonin—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000123	0.000734	CcSEcCtD
Melatonin—Nausea—Dexamethasone—multiple sclerosis	0.000123	0.000733	CcSEcCtD
Melatonin—Nausea—Betamethasone—multiple sclerosis	0.000123	0.000733	CcSEcCtD
Melatonin—Dizziness—Prednisone—multiple sclerosis	0.000119	0.000711	CcSEcCtD
Melatonin—Abdominal pain—Methotrexate—multiple sclerosis	0.000119	0.00071	CcSEcCtD
Melatonin—Vomiting—Prednisone—multiple sclerosis	0.000115	0.000683	CcSEcCtD
Melatonin—Rash—Prednisone—multiple sclerosis	0.000114	0.000678	CcSEcCtD
Melatonin—Dermatitis—Prednisone—multiple sclerosis	0.000114	0.000677	CcSEcCtD
Melatonin—Headache—Prednisone—multiple sclerosis	0.000113	0.000673	CcSEcCtD
Melatonin—Hypersensitivity—Methotrexate—multiple sclerosis	0.000111	0.000662	CcSEcCtD
Melatonin—Asthenia—Methotrexate—multiple sclerosis	0.000108	0.000644	CcSEcCtD
Melatonin—Nausea—Prednisone—multiple sclerosis	0.000107	0.000638	CcSEcCtD
Melatonin—Pruritus—Methotrexate—multiple sclerosis	0.000107	0.000635	CcSEcCtD
Melatonin—Dizziness—Methotrexate—multiple sclerosis	9.98e-05	0.000594	CcSEcCtD
Melatonin—Vomiting—Methotrexate—multiple sclerosis	9.6e-05	0.000571	CcSEcCtD
Melatonin—Rash—Methotrexate—multiple sclerosis	9.52e-05	0.000566	CcSEcCtD
Melatonin—Dermatitis—Methotrexate—multiple sclerosis	9.51e-05	0.000566	CcSEcCtD
Melatonin—Headache—Methotrexate—multiple sclerosis	9.46e-05	0.000563	CcSEcCtD
Melatonin—Nausea—Methotrexate—multiple sclerosis	8.97e-05	0.000533	CcSEcCtD
Melatonin—CALM1—Hemostasis—IL2—multiple sclerosis	1.15e-05	5.27e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—CCR5—multiple sclerosis	1.14e-05	5.24e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—CCR5—multiple sclerosis	1.14e-05	5.24e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—CD8A—multiple sclerosis	1.14e-05	5.23e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—CD8A—multiple sclerosis	1.14e-05	5.23e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.13e-05	5.21e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—HLA-B—multiple sclerosis	1.13e-05	5.2e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PGR—multiple sclerosis	1.13e-05	5.2e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CD86—multiple sclerosis	1.12e-05	5.17e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—IL2RA—multiple sclerosis	1.12e-05	5.16e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—IL2RA—multiple sclerosis	1.12e-05	5.16e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—CD4—multiple sclerosis	1.12e-05	5.16e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—CD4—multiple sclerosis	1.12e-05	5.16e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—CD86—multiple sclerosis	1.12e-05	5.15e-05	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—CD4—multiple sclerosis	1.11e-05	5.12e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PTGER4—multiple sclerosis	1.11e-05	5.11e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PTGER4—multiple sclerosis	1.11e-05	5.11e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CXCR3—multiple sclerosis	1.11e-05	5.1e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CCL5—multiple sclerosis	1.1e-05	5.09e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by NGF—IL6—multiple sclerosis	1.1e-05	5.06e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CD28—multiple sclerosis	1.1e-05	5.06e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—HLA-B—multiple sclerosis	1.09e-05	5.03e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—HLA-B—multiple sclerosis	1.09e-05	5.03e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PGR—multiple sclerosis	1.09e-05	5.03e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PGR—multiple sclerosis	1.09e-05	5.03e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—CD86—multiple sclerosis	1.08e-05	4.98e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—CD86—multiple sclerosis	1.08e-05	4.98e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CCR2—multiple sclerosis	1.08e-05	4.96e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—CD4—multiple sclerosis	1.08e-05	4.96e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—CD4—multiple sclerosis	1.08e-05	4.96e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CXCR3—multiple sclerosis	1.07e-05	4.94e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CXCR3—multiple sclerosis	1.07e-05	4.94e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by NGF—IL6—multiple sclerosis	1.06e-05	4.89e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by NGF—IL6—multiple sclerosis	1.06e-05	4.89e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CD28—multiple sclerosis	1.06e-05	4.89e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CD28—multiple sclerosis	1.06e-05	4.89e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—IL2RA—multiple sclerosis	1.06e-05	4.88e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—HLA-A—multiple sclerosis	1.05e-05	4.82e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CCR2—multiple sclerosis	1.04e-05	4.8e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CCR2—multiple sclerosis	1.04e-05	4.8e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—POMC—multiple sclerosis	1.04e-05	4.78e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.03e-05	4.75e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.03e-05	4.75e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.03e-05	4.73e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—IL2RA—multiple sclerosis	1.02e-05	4.72e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—IL2RA—multiple sclerosis	1.02e-05	4.72e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—SPP1—multiple sclerosis	1.02e-05	4.71e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—HLA-A—multiple sclerosis	1.01e-05	4.66e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—HLA-A—multiple sclerosis	1.01e-05	4.66e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—POMC—multiple sclerosis	1e-05	4.61e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CCR5—multiple sclerosis	9.95e-06	4.58e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CNR1—multiple sclerosis	9.95e-06	4.58e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—CCR5—multiple sclerosis	9.92e-06	4.57e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—IL2RA—multiple sclerosis	9.81e-06	4.52e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—BCHE—multiple sclerosis	9.76e-06	4.49e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—HLA-A—multiple sclerosis	9.67e-06	4.45e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CNR1—multiple sclerosis	9.63e-06	4.43e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CNR1—multiple sclerosis	9.63e-06	4.43e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—CCR5—multiple sclerosis	9.6e-06	4.42e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—CCR5—multiple sclerosis	9.6e-06	4.42e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—TLR4—multiple sclerosis	9.58e-06	4.41e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—HLA-DRB1—multiple sclerosis	9.57e-06	4.41e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—ALB—multiple sclerosis	9.47e-06	4.36e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.41e-06	4.33e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—HLA-A—multiple sclerosis	9.35e-06	4.31e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—HLA-A—multiple sclerosis	9.35e-06	4.31e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—TLR4—multiple sclerosis	9.27e-06	4.27e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—TLR4—multiple sclerosis	9.27e-06	4.27e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—HLA-DRB1—multiple sclerosis	9.26e-06	4.26e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—HLA-DRB1—multiple sclerosis	9.26e-06	4.26e-05	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—TGFB1—multiple sclerosis	9.24e-06	4.25e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—POMC—multiple sclerosis	9.19e-06	4.23e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—ICAM1—multiple sclerosis	9.18e-06	4.23e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—ALB—multiple sclerosis	9.12e-06	4.2e-05	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—MAPK1—multiple sclerosis	9.06e-06	4.17e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—APOE—multiple sclerosis	9.06e-06	4.17e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—APOE—multiple sclerosis	9.03e-06	4.16e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—CCL2—multiple sclerosis	8.99e-06	4.14e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CXCL10—multiple sclerosis	8.96e-06	4.13e-05	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—TGFB1—multiple sclerosis	8.94e-06	4.11e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—TGFB1—multiple sclerosis	8.94e-06	4.11e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—BCHE—multiple sclerosis	8.9e-06	4.1e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—POMC—multiple sclerosis	8.89e-06	4.09e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—POMC—multiple sclerosis	8.89e-06	4.09e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—ICAM1—multiple sclerosis	8.88e-06	4.09e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—ICAM1—multiple sclerosis	8.88e-06	4.09e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—CD80—multiple sclerosis	8.84e-06	4.07e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.82e-06	4.06e-05	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—MAPK1—multiple sclerosis	8.76e-06	4.03e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—MAPK1—multiple sclerosis	8.76e-06	4.03e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—APOE—multiple sclerosis	8.73e-06	4.02e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—APOE—multiple sclerosis	8.73e-06	4.02e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—CCL2—multiple sclerosis	8.7e-06	4.01e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—CCL2—multiple sclerosis	8.7e-06	4.01e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CXCL10—multiple sclerosis	8.67e-06	3.99e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CXCL10—multiple sclerosis	8.67e-06	3.99e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—CD80—multiple sclerosis	8.55e-06	3.94e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—CD80—multiple sclerosis	8.55e-06	3.94e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CD80—multiple sclerosis	8.19e-06	3.77e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—TYK2—multiple sclerosis	8.17e-06	3.76e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—CD80—multiple sclerosis	8.16e-06	3.76e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—MAPK1—multiple sclerosis	8.16e-06	3.75e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.04e-06	3.7e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—TYK2—multiple sclerosis	7.9e-06	3.64e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—TYK2—multiple sclerosis	7.9e-06	3.64e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—CD80—multiple sclerosis	7.9e-06	3.64e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—CD80—multiple sclerosis	7.9e-06	3.64e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—MAPK1—multiple sclerosis	7.89e-06	3.63e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—MAPK1—multiple sclerosis	7.89e-06	3.63e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CD86—multiple sclerosis	7.83e-06	3.61e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—POMC—multiple sclerosis	7.78e-06	3.58e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CCL5—multiple sclerosis	7.71e-06	3.55e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CCL2—multiple sclerosis	7.61e-06	3.5e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—BCHE—multiple sclerosis	7.6e-06	3.5e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CD86—multiple sclerosis	7.58e-06	3.49e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CD86—multiple sclerosis	7.58e-06	3.49e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—APOE—multiple sclerosis	7.56e-06	3.48e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—TYK2—multiple sclerosis	7.46e-06	3.44e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CCL5—multiple sclerosis	7.46e-06	3.44e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CCL5—multiple sclerosis	7.46e-06	3.44e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—APOE—multiple sclerosis	7.31e-06	3.37e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—APOE—multiple sclerosis	7.31e-06	3.37e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—TYK2—multiple sclerosis	7.22e-06	3.32e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—TYK2—multiple sclerosis	7.22e-06	3.32e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—APOE—multiple sclerosis	7.17e-06	3.3e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—SPP1—multiple sclerosis	7.14e-06	3.29e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—IFNG—multiple sclerosis	6.99e-06	3.22e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CCR5—multiple sclerosis	6.95e-06	3.2e-05	CbGpPWpGaD
Melatonin—ESR1—Gene Expression—MYC—multiple sclerosis	6.92e-06	3.18e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TYK2—multiple sclerosis	6.91e-06	3.18e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SPP1—multiple sclerosis	6.91e-06	3.18e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SPP1—multiple sclerosis	6.91e-06	3.18e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—TYK2—multiple sclerosis	6.89e-06	3.17e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IL2RA—multiple sclerosis	6.85e-06	3.15e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—IL2—multiple sclerosis	6.8e-06	3.13e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—IFNG—multiple sclerosis	6.76e-06	3.11e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—IFNG—multiple sclerosis	6.76e-06	3.11e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—CD4—multiple sclerosis	6.75e-06	3.11e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CCR5—multiple sclerosis	6.72e-06	3.09e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CCR5—multiple sclerosis	6.72e-06	3.09e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—TYK2—multiple sclerosis	6.67e-06	3.07e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—TYK2—multiple sclerosis	6.67e-06	3.07e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IL2RA—multiple sclerosis	6.62e-06	3.05e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IL2RA—multiple sclerosis	6.62e-06	3.05e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—IL2—multiple sclerosis	6.57e-06	3.03e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—IL2—multiple sclerosis	6.57e-06	3.03e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—CD4—multiple sclerosis	6.53e-06	3.01e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—CD4—multiple sclerosis	6.53e-06	3.01e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—POMC—multiple sclerosis	6.49e-06	2.99e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—APOE—multiple sclerosis	6.32e-06	2.91e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—POMC—multiple sclerosis	6.28e-06	2.89e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—POMC—multiple sclerosis	6.28e-06	2.89e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—IL6—multiple sclerosis	6.27e-06	2.89e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—IL1B—multiple sclerosis	6.23e-06	2.87e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—CD4—multiple sclerosis	6.23e-06	2.87e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—IL2—multiple sclerosis	6.21e-06	2.86e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—POMC—multiple sclerosis	6.16e-06	2.84e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—APOE—multiple sclerosis	6.12e-06	2.82e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—APOE—multiple sclerosis	6.12e-06	2.82e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—IL6—multiple sclerosis	6.06e-06	2.79e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—IL6—multiple sclerosis	6.06e-06	2.79e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—IL1B—multiple sclerosis	6.03e-06	2.78e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—IL1B—multiple sclerosis	6.03e-06	2.78e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—CD4—multiple sclerosis	6.03e-06	2.78e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—CD4—multiple sclerosis	6.03e-06	2.78e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—IL2—multiple sclerosis	6.01e-06	2.77e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—IL2—multiple sclerosis	6.01e-06	2.77e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—ALB—multiple sclerosis	5.92e-06	2.73e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—APOE—multiple sclerosis	5.87e-06	2.7e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—IL2—multiple sclerosis	5.75e-06	2.65e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—ALB—multiple sclerosis	5.73e-06	2.64e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—ALB—multiple sclerosis	5.73e-06	2.64e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CD80—multiple sclerosis	5.72e-06	2.63e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—ALB—multiple sclerosis	5.62e-06	2.59e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CD80—multiple sclerosis	5.53e-06	2.55e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CD80—multiple sclerosis	5.53e-06	2.55e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MMP9—multiple sclerosis	5.44e-06	2.51e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—POMC—multiple sclerosis	5.43e-06	2.5e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—APOE—multiple sclerosis	5.35e-06	2.46e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CCL2—multiple sclerosis	5.31e-06	2.45e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—POMC—multiple sclerosis	5.25e-06	2.42e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—POMC—multiple sclerosis	5.25e-06	2.42e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—STAT3—multiple sclerosis	5.23e-06	2.41e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—MAPK1—multiple sclerosis	5.2e-06	2.39e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CCL2—multiple sclerosis	5.14e-06	2.37e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CCL2—multiple sclerosis	5.14e-06	2.37e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—STAT3—multiple sclerosis	5.05e-06	2.33e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—STAT3—multiple sclerosis	5.05e-06	2.33e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—POMC—multiple sclerosis	5.04e-06	2.32e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—MAPK1—multiple sclerosis	5.03e-06	2.32e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—MAPK1—multiple sclerosis	5.03e-06	2.32e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—STAT3—multiple sclerosis	4.84e-06	2.23e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TYK2—multiple sclerosis	4.83e-06	2.22e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—STAT3—multiple sclerosis	4.82e-06	2.22e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—MAPK1—multiple sclerosis	4.75e-06	2.19e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TYK2—multiple sclerosis	4.67e-06	2.15e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TYK2—multiple sclerosis	4.67e-06	2.15e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—STAT3—multiple sclerosis	4.67e-06	2.15e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—STAT3—multiple sclerosis	4.67e-06	2.15e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—POMC—multiple sclerosis	4.6e-06	2.12e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—ALB—multiple sclerosis	4.6e-06	2.12e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—MAPK1—multiple sclerosis	4.6e-06	2.12e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—MAPK1—multiple sclerosis	4.6e-06	2.12e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—APOE—multiple sclerosis	4.57e-06	2.11e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MYC—multiple sclerosis	4.5e-06	2.07e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TGFB1—multiple sclerosis	4.49e-06	2.07e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—MYC—multiple sclerosis	4.48e-06	2.06e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—TGFB1—multiple sclerosis	4.47e-06	2.06e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MAPK1—multiple sclerosis	4.4e-06	2.03e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—MAPK1—multiple sclerosis	4.39e-06	2.02e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—MYC—multiple sclerosis	4.34e-06	2e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—MYC—multiple sclerosis	4.34e-06	2e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—TGFB1—multiple sclerosis	4.33e-06	1.99e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—TGFB1—multiple sclerosis	4.33e-06	1.99e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—MAPK1—multiple sclerosis	4.24e-06	1.95e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—MAPK1—multiple sclerosis	4.24e-06	1.95e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—ALB—multiple sclerosis	4.19e-06	1.93e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IL2—multiple sclerosis	4.01e-06	1.85e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—IL6—multiple sclerosis	3.99e-06	1.84e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—POMC—multiple sclerosis	3.93e-06	1.81e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IL2—multiple sclerosis	3.88e-06	1.79e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IL2—multiple sclerosis	3.88e-06	1.79e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—IL6—multiple sclerosis	3.86e-06	1.78e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—IL6—multiple sclerosis	3.86e-06	1.78e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MMP9—multiple sclerosis	3.8e-06	1.75e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MMP9—multiple sclerosis	3.68e-06	1.69e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MMP9—multiple sclerosis	3.68e-06	1.69e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—IL6—multiple sclerosis	3.65e-06	1.68e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—ALB—multiple sclerosis	3.58e-06	1.65e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—IL6—multiple sclerosis	3.53e-06	1.63e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—IL6—multiple sclerosis	3.53e-06	1.63e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—IL6—multiple sclerosis	3.38e-06	1.56e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—STAT3—multiple sclerosis	3.38e-06	1.56e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—IL6—multiple sclerosis	3.37e-06	1.55e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—STAT3—multiple sclerosis	3.27e-06	1.5e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—STAT3—multiple sclerosis	3.27e-06	1.5e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—IL6—multiple sclerosis	3.26e-06	1.5e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—IL6—multiple sclerosis	3.26e-06	1.5e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MYC—multiple sclerosis	3.14e-06	1.45e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TGFB1—multiple sclerosis	3.13e-06	1.44e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MAPK1—multiple sclerosis	3.07e-06	1.41e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MYC—multiple sclerosis	3.04e-06	1.4e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MYC—multiple sclerosis	3.04e-06	1.4e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TGFB1—multiple sclerosis	3.03e-06	1.39e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TGFB1—multiple sclerosis	3.03e-06	1.39e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MAPK1—multiple sclerosis	2.97e-06	1.37e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MAPK1—multiple sclerosis	2.97e-06	1.37e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IL6—multiple sclerosis	2.36e-06	1.09e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IL6—multiple sclerosis	2.28e-06	1.05e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IL6—multiple sclerosis	2.28e-06	1.05e-05	CbGpPWpGaD
